Company news
Genomma Lab Internacional Sab De Cv Class B (BMV:LAB/B) news
Genomma Lab Internacional Sab De Cv Class B news releases on 6ix. Latest, Apr 23, 2026: LAB/B: Net sales fell 4.9% as FX and weak demand weighed, but LATAM…
Press releases & updates
LAB/B: Net sales fell 4.9% as FX and weak demand weighed, but LATAM growth and margin gains offset declines
April 23, 2026
LAB/B: Margins held strong despite sales decline, with recovery and growth initiatives set for 2026
February 26, 2026
LAB/B: Sales declined due to hyperinflation and weak demand, but margins and cost controls remained strong
October 23, 2025
LAB/B: Solid EBITDA margin and free cash flow growth offset weak sales and currency headwinds
July 24, 2025
LAB/B: Q1 2025 saw robust EBITDA and EPS growth, with strong cash flow and margin gains
May 2, 2025
LAB/B: Exceptional 2024 results: strong sales, record profits, margin expansion, and robust cash flow
February 27, 2025
LAB/B: Q3 delivered robust sales, margin, and cash flow growth, with strong outlook and disciplined capital use
October 24, 2024
LAB/B: Q2 2024 delivered strong profit growth, margin expansion, and strategic M&A activity
July 25, 2024